13.07.2015 Views

Hypoglycaemia in Clinical Diabetes

Hypoglycaemia in Clinical Diabetes

Hypoglycaemia in Clinical Diabetes

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

AGE, OBESITY AND GLUCOSE COUNTERREGULATION 133GlucoseDeliveryUtilisationAdenos<strong>in</strong>eCaffe<strong>in</strong>eFigure 6.11 Caffe<strong>in</strong>e may act by uncoupl<strong>in</strong>g bra<strong>in</strong> glucose demand (<strong>in</strong>creased) and substrate delivery(decreased) through its actions on adenos<strong>in</strong>e receptors. Reproduced from Bra<strong>in</strong> Research Reviews, 17,Nehlig et al., 139–169, Copyright (1992), with permission from Elsevierof the area with glucose suppresses these responses dur<strong>in</strong>g systemic hypoglycaemia (Borget al., 1995; Borg et al., 1997). The mechanisms <strong>in</strong>volved are unknown but may be a consequenceof <strong>in</strong>creased glucok<strong>in</strong>ase activity to enhance glucose metabolism <strong>in</strong> neurones <strong>in</strong> theregion (Gabriely and Shamoon, 2005). However, it is likely that bra<strong>in</strong> metabolism <strong>in</strong> areasand other signall<strong>in</strong>g mechanisms with<strong>in</strong> the CNS are <strong>in</strong>fluenced by recurrent antecedenthypoglycaemia (Cryer, 2005).The bra<strong>in</strong> glycogen supercompensation hypothesis suggests that after a s<strong>in</strong>gle episodeof hypoglycaemia, there is a rebound <strong>in</strong>crease <strong>in</strong> glycogen formation <strong>in</strong> bra<strong>in</strong> astrocytes toprovide additional substrates (e.g. lactate) for bra<strong>in</strong> metabolism (Choi et al., 2003). Alterationsof substrate delivery to the bra<strong>in</strong> do appear to <strong>in</strong>fluence the magnitude of the hormonalcounterregulatory response to hypoglycaemia <strong>in</strong> healthy volunteers and <strong>in</strong> patients with type1 diabetes. Infusions of acetazolamide, a potent cerebral vasodilator, markedly attenuatesthese responses (Thomas et al., 1997) whereas <strong>in</strong>gestion of modest amounts of caffe<strong>in</strong>e (toreduce substrate delivery) augments the responses (Debrah et al., 1996). The mechanismsof the latter is unknown but may <strong>in</strong>volve antagonism of central adenos<strong>in</strong>e receptors withuncoupl<strong>in</strong>g of bra<strong>in</strong> blood flow (i.e., substrate delivery) and bra<strong>in</strong> glucose metabolism (i.e.,bra<strong>in</strong> glucose demand) result<strong>in</strong>g <strong>in</strong> relative cerebral neuroglycopenia (Figure 6.11). This isdiscussed <strong>in</strong> more detail <strong>in</strong> Chapter 5.AGE, OBESITY AND GLUCOSE COUNTERREGULATIONIn children with type 1 diabetes, the glucagon response to hypoglycaemia is markedly attenuatedcompared to non-diabetic <strong>in</strong>dividuals but compensated for by vigorous secretion of othercounterregulatory hormones, particularly ep<strong>in</strong>ephr<strong>in</strong>e, with the peak ep<strong>in</strong>ephr<strong>in</strong>e responsesbe<strong>in</strong>g almost two-fold higher than <strong>in</strong> adults (Amiel et al., 1987). The total sympathoadrenalresponses to hypoglycaemia are also <strong>in</strong>fluenced by pubertal stage (Ross et al., 2005).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!